Phosphate Quiz: Can You Balance It?

1. True or False: Hyperphosphatemia in chronic kidney disease accelerates vascular calcification and increases cardiovascular mortality risk.

True

False

2. A patient with severe hypophosphatemia (0.7 mg/dL) receiving IV phosphate supplementation suddenly develops hypocalcemia and tetany. What is the most likely cause?

Rapid phosphate repletion causing precipitation of calcium-phosphate complexes

Hypomagnesemia from excessive diuresis

Acute pancreatitis triggered by refeeding

Vitamin D deficiency unmasked during repletion

3. A 68-year-old with stage 4 CKD (GFR 18 mL/min) has a phosphate level of 5.8 mg/dL despite dietary restriction. What is the most effective long-term management strategy?

Phosphate binders plus dialysis when GFR falls below 15

Increased dietary calcium intake alone

Vitamin D supplementation without binders

ACE inhibitors to slow disease progression

4. Which diagnostic finding would be expected in a patient with symptomatic hypophosphatemia from refeeding syndrome?

Low serum phosphate, low magnesium, and low potassium

High serum phosphate with normal magnesium

Normal phosphate with elevated creatinine

Low phosphate with hyperglycemia only

5. A patient on mechanical ventilation with ARDS has a phosphate level of 1.3 mg/dL and cannot wean from the ventilator. How does hypophosphatemia contribute to this clinical picture?

Impaired diaphragmatic muscle strength and respiratory muscle fatigue

Increased intracranial pressure from cerebral edema

Acute coronary syndrome from electrolyte imbalance

Sepsis-induced myocardial depression

6. A 45-year-old with alcoholic cirrhosis presents with tremors and altered mental status. Serum phosphate is 1.2 mg/dL. What is the expected cause of hypophosphatemia?

Malnutrition, poor intake, and refeeding syndrome risk

Hepatic phosphate synthesis impairment

Increased urinary losses from portal hypertension

Decreased intestinal absorption from ascites

7. A patient with hypophosphatemia requires supplementation. Which route and form would be most appropriate for severe symptomatic deficiency?

IV potassium phosphate

Oral phosphate binders

IM calcium phosphate

Transdermal phosphate patch

8. A 58-year-old patient with chronic kidney disease has a serum phosphate level of 6.2 mg/dL (normal 2.5–4.5). What is the primary mechanism causing this phosphate imbalance?

Decreased glomerular filtration and reduced renal excretion

Increased gastrointestinal absorption of phosphate

Shift of phosphate from intracellular to extracellular space

Excessive use of phosphate-binding antacids

9. A patient with severe hypophosphatemia (0.8 mg/dL) develops rhabdomyolysis. What is the primary pathophysiologic mechanism?

Impaired ATP production and muscle cell dysfunction

Direct toxicity to muscle mitochondria

Hyperkalemia-induced muscle depolarization

Acute liver failure reducing protein synthesis

10. A 72-year-old with hyperphosphatemia secondary to chronic kidney disease reports bone pain and itching. Which complication is most likely responsible for these symptoms?

Secondary hyperparathyroidism and calcium-phosphate precipitation

Acute tubular necrosis

Hypermagnesemia

Metabolic alkalosis

11. A patient with acute leukemia undergoing chemotherapy develops hyperphosphatemia and hypocalcemia. What underlying process explains this phosphate imbalance?

Tumor lysis syndrome releasing intracellular phosphate

Renal tubular dysfunction from chemotherapy agents

Increased parathyroid hormone secretion

Vitamin D deficiency from bone marrow suppression

12. Which medication is commonly used to manage hyperphosphatemia by binding phosphate in the gastrointestinal tract?

Aluminum hydroxide

Omeprazole

Metoprolol

Furosemide

13. A patient receiving total parenteral nutrition (TPN) develops tremors, confusion, and muscle pain. Serum phosphate is 1.1 mg/dL. What is the most appropriate initial intervention?

Add phosphate supplementation to TPN

Increase caloric content of TPN

Administer calcium gluconate IV

Switch to enteral nutrition immediately

14. Which patient population is at highest risk for severe symptomatic hypophosphatemia?

Those receiving prolonged IV dextrose infusions without phosphate supplementation

Patients with primary hyperparathyroidism

Those on long-term corticosteroid therapy

Patients with hyperthyroidism

15. Which acid-base disturbance is commonly associated with chronic hyperphosphatemia?

Metabolic acidosis from reduced renal acid excretion

Respiratory alkalosis from hyperventilation

Metabolic alkalosis from volume contraction

Respiratory acidosis from muscle weakness

16. True or False: Hypophosphatemia is commonly seen in patients with diabetic ketoacidosis during the recovery phase.

True

False

17. True or False: Hyperphosphatemia directly stimulates parathyroid hormone secretion, creating a feedback loop in chronic kidney disease.

True

False

18. Which clinical finding is most consistent with acute hypophosphatemia?

Muscle weakness and respiratory depression

Hyperreflexia and tetany

Increased bone density on imaging

Hypertension and fluid retention

19. True or False: Hypophosphatemia impairs 2,3-DPG production in red blood cells, shifting the oxygen-hemoglobin dissociation curve leftward and reducing oxygen delivery to tissues.

True

False

Phosphate Quiz: Can You Balance It?

1. True or False: Hyperphosphatemia in chronic kidney disease accelerates vascular calcification and increases cardiovascular mortality risk.

2.

What first name or nickname would you like us to use?

2. A patient with severe hypophosphatemia (0.7 mg/dL) receiving IV phosphate supplementation suddenly develops hypocalcemia and tetany. What is the most likely cause?

3. A 68-year-old with stage 4 CKD (GFR 18 mL/min) has a phosphate level of 5.8 mg/dL despite dietary restriction. What is the most effective long-term management strategy?

4. Which diagnostic finding would be expected in a patient with symptomatic hypophosphatemia from refeeding syndrome?

5. A patient on mechanical ventilation with ARDS has a phosphate level of 1.3 mg/dL and cannot wean from the ventilator. How does hypophosphatemia contribute to this clinical picture?

6. A 45-year-old with alcoholic cirrhosis presents with tremors and altered mental status. Serum phosphate is 1.2 mg/dL. What is the expected cause of hypophosphatemia?

7. A patient with hypophosphatemia requires supplementation. Which route and form would be most appropriate for severe symptomatic deficiency?

8. A 58-year-old patient with chronic kidney disease has a serum phosphate level of 6.2 mg/dL (normal 2.5–4.5). What is the primary mechanism causing this phosphate imbalance?

9. A patient with severe hypophosphatemia (0.8 mg/dL) develops rhabdomyolysis. What is the primary pathophysiologic mechanism?

10. A 72-year-old with hyperphosphatemia secondary to chronic kidney disease reports bone pain and itching. Which complication is most likely responsible for these symptoms?

11. A patient with acute leukemia undergoing chemotherapy develops hyperphosphatemia and hypocalcemia. What underlying process explains this phosphate imbalance?

12. Which medication is commonly used to manage hyperphosphatemia by binding phosphate in the gastrointestinal tract?

13. A patient receiving total parenteral nutrition (TPN) develops tremors, confusion, and muscle pain. Serum phosphate is 1.1 mg/dL. What is the most appropriate initial intervention?

14. Which patient population is at highest risk for severe symptomatic hypophosphatemia?

15. Which acid-base disturbance is commonly associated with chronic hyperphosphatemia?

16. True or False: Hypophosphatemia is commonly seen in patients with diabetic ketoacidosis during the recovery phase.

17. True or False: Hyperphosphatemia directly stimulates parathyroid hormone secretion, creating a feedback loop in chronic kidney disease.

18. Which clinical finding is most consistent with acute hypophosphatemia?

19. True or False: Hypophosphatemia impairs 2,3-DPG production in red blood cells, shifting the oxygen-hemoglobin dissociation curve leftward and reducing oxygen delivery to tissues.